LobbyingSebela Pharmaceuticals lobbying by quarter
Sebela Pharmaceuticals's latest lobbying report covers Q2 2026, at $40K. The four quarters Q3 2025–Q2 2026 total $160K. Its first report covers Q4 2023; the issues it reports most are Health Issues.
Sebela Pharmaceuticals
- Latest quarter
- $40K
- Q2 2026 · 1 reports
- Last 12 months
- $160K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
Policy issues the reports name
- Health issues8 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES8 reports
- SENATE8 reports
- Centers For Medicare and Medicaid Services (CMS)7 reports
- White House Office2 reports
- Labor, Dept of (DOL)1 reports
- Treasury, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The KPM Group DC | $440K | 11 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | The KPM Group DC | $40K |
| 04/20for Q1 | The KPM Group DC | $40K |
| 01/14for Q4 2025 | The KPM Group DC | $40K |
| 25/10/07for Q3 2025 | The KPM Group DC | $40K |
| 25/10/07for Q3 2025 | The KPM Group DC | $40K |
| 25/07/17for Q2 2025 | The KPM Group DC | $40K |
| 25/04/21for Q1 2025 | The KPM Group DC | $40K |
| 25/01/21for Q4 2024 | The KPM Group DC | $40K |
| 24/10/21for Q3 2024 | The KPM Group DC | $40K |
| 24/07/19for Q2 2024 | The KPM Group DC | $40K |
| 24/04/19for Q1 2024 | The KPM Group DC | $40K |
| 24/01/22for Q4 2023 | The KPM Group DC | $40K |
| 23/10/10for Q4 2023 | The KPM Group DC | Under $5,000 |